ITGR · Integer Holdings Corp
Market Cap
$4.26B
Shares
33.99M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | Former President and CEO | $8,671,332 |
| Payman Khales | President and CEO | $3,211,860 |
| Diron Smith | Executive Vice President and Chief Financial Officer | $2,568,964 |
| Andrew Senn | President, Cardio & Vascular | $1,707,924 |
| Jim Stephens | President, Cardiac Rhythm Management & Neuromodulation | $1,692,650 |
| Lindsay K. Blackwood | Senior Vice President, General Counsel and Corporate Secretary | $1,643,897 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $8,675,379 |
| Diron Smith | Executive Vice President and Chief Financial Officer | $2,472,797 |
| Payman Khales | President, Cardio & Vascular | $1,976,810 |
| John Harris | Executive Vice President, Global Operations and Manufacturing Strategy | $1,867,482 |
| Jim Stephens | President, Cardiac Rhythm Management & Neuromodulation | $1,600,604 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $8,738,497 |
| Payman Khales | President, Cardio & Vascular | $4,036,646 |
| Jason Garland | Former Executive Vice President and Chief Financial Officer | $2,326,532 |
| Jennifer M. Bolt | Former Executive Vice President, Global Operations and ESG | $1,500,923 |
| Kirk Thor | Executive Vice President and Chief Human Resources Officer | $1,336,615 |
| McAlister Marshall | Senior Vice President, General Counsel, Chief Ethics and Compliance Officer and Corporate Secretary | $1,334,830 |
| Diron Smith | Executive Vice President and Chief Financial Officer | $1,281,207 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $11,495,237 |
| Jason Garland | Former Executive Vice President and Chief Financial Officer | $3,160,549 |
| Payman Khales | President, Cardio & Vascular | $2,302,847 |
| Carter Houghton | President, Electrochem and Power Solutions | $1,418,569 |
| Jennifer M. Bolt | Former Executive Vice President, Global Operations and ESG | $1,158,552 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $6,922,075 |
| Jason Garland | Former Executive Vice President and Chief Financial Officer | $1,882,215 |
| Payman Khales | President, Cardio & Vascular | $1,385,147 |
| Jennifer M. Bolt | Former Executive Vice President, Global Operations and ESG | $1,330,755 |
| Joel Becker | President, Cardiac Rhythm Management & Neuromodulation | $1,227,172 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $5,923,784 |
| Jason Garland | Executive Vice President and Chief Financial Officer | $1,702,647 |
| Payman Khales | President, Cardio & Vascular | $1,135,259 |
| Joel Becker | President, Cardiac Rhythm Management & Neuromodulation | $1,084,321 |
| Jennifer M. Bolt | Executive Vice President, Global Operations and ESG | $1,015,759 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $5,744,889 |
| Jason Garland | Executive Vice President and Chief Financial Officer | $1,879,934 |
| Carter Houghton | President, Electrochem and Power Solutions | $1,358,447 |
| Payman Khales | President, Cardio & Vascular | $1,091,563 |
| Jennifer M. Bolt | Senior Vice President, Global Operations and ESG | $1,065,455 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President and Chief Executive Officer | $5,383,625 |
| Jason Garland | Executive Vice President and Chief Financial Officer | $796,284 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Joseph Dziedzic | President & Chief Executive Officer | $4,888,772 |
Key facts
CIK
1114483
CUSIP
45826H109
13F (30d)
248 filings
245 filers
Visit website
Investor relations